Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01937195 · ClinicalTrials.gov registry record · NA
AccuCath™ Intravenous (IV) Device Used by Vascular Access Team (VAT)
A NA study, sponsored by C. R. Bard.
- Completed
- Registry status
- NA
- Development phase
- 95
- Enrollment target
NCT01937195 is a NA study that has completed, run by C. R. Bard. The registered enrollment target is 95 participants.
The verdict
NCT01937195, a NA study, has completed, sponsored by C. R. Bard.
- COMPLETED
- Registry status
- NA
- Development phase
- 95 participants
- Enrollment target
Study Summary
The study will test a hypothesis that the AccuCath™ System will have a higher rate of successful first attempt peripheral intravenous (PIV) placement, higher completion of therapy, fewer complications, longer dwell times, and higher user satisfaction compared to Conventional IV Catheters.
Interventions
- DEVICE AccuCath Intravenous Catheter System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2013-04 |
| Est. Completion | 2014-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01937195
The ClinicalTrials.gov registry entry for NCT01937195 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is C. R. Bard, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AccuCath Intravenous Catheter System is the first listed.
NCT01937195 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01937195 about?
NCT01937195 is a clinical study titled "AccuCath™ Intravenous (IV) Device Used by Vascular Access Team (VAT)". The study will test a hypothesis that the AccuCath™ System will have a higher rate of successful first attempt peripheral intravenous (PIV) placement, higher completion of therapy, fewer complications, longer dwell times, and higher user satisfaction compared to Conventional IV Catheters.
What is the current status of trial NCT01937195?
This trial is currently completed. It is a NA study. The enrollment target is 95 participants. The study started on 2013-04. Estimated completion is 2014-11.
What interventions are being tested in trial NCT01937195?
The interventions under investigation include: AccuCath Intravenous Catheter System (DEVICE).
Who is sponsoring clinical trial NCT01937195?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.